GOLDEN, Colo.--(BUSINESS WIRE)--A clinical study published in the August 23, 2014 issue of The Lancet demonstrated that delivery of AFLURIA® (Influenza Vaccine) with the PharmaJet Needle-Free Injector compared favorably to traditional needle and syringe delivery. The U.S. Food and Drug Administration (FDA) recently approved the Stratis® 0.5mL Needle-Free Jet Injector for delivery of AFLURIA in people aged 18 through 64 years. It is the first influenza vaccine in the U.S. to be labeled for administration with a jet injector and will be available for use during the upcoming 2014-2015 flu vaccination season.
